Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Argus Research Upgrades Church Dwight Co to Buy Sets New Price Target

Elaine Mendonca by Elaine Mendonca
February 23, 2024
in Breaking News
0
Consumer Goods Stock Market Today
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

On February 23, 2024, Argus Research analyst Taylor Conrad made a bold move by upgrading Church & Dwight Co (NYSE:CHD) from Hold to Buy, with a new price target of $115. This upgrade reflects a bullish perspective on the stock’s future.

Argus has been vocal about the strength of Church & Dwight’s “power brands” and has reiterated their Buy rating. It’s worth mentioning that in the past, Argus had downgraded Church & Dwight to Hold citing sales and cost issues. However, this recent upgrade indicates a shift in sentiment and a renewed confidence in the company’s potential for growth.

Investors should take note of this upgrade as it could signal a positive trajectory for Church & Dwight moving forward.

Church & Dwight Co., Inc. (CHD) Shows Strong Stock Performance on February 23, 2024

On February 23, 2024, Church & Dwight Co., Inc. (CHD) showed strong performance in the stock market. According to data from CNN Money, CHD is currently trading near the top of its 52-week range and above its 200-day simple moving average.

The price of CHD shares increased by $0.14 since the market last closed, representing a 0.14% rise. The stock opened at $100.39, which was $0.75 higher than its previous close. This positive price momentum suggests that investors have confidence in the company’s performance and future prospects.

Church & Dwight Co., Inc. is a consumer goods company that produces a variety of household and personal care products. With a strong portfolio of well-known brands such as Arm & Hammer, Trojan, and OxiClean, CHD has established itself as a leader in the industry.

Investors may be drawn to CHD for its consistent growth and profitability. The company has a track record of delivering strong financial results and has continued to innovate and expand its product offerings to meet changing consumer preferences.

Overall, CHD’s stock performance on February 23, 2024, reflects the company’s solid fundamentals and positive market sentiment. Investors will be closely watching to see if the stock can maintain its momentum and continue to deliver value in the future.

CHD Stock Performance Analysis: Revenue and Net Income Increase, Earnings per Share Decrease

On February 23, 2024, CHD stock performance showed some interesting trends based on the financial data provided by CNN Money. Total revenue for CHD stood at $5.87 billion over the past year, with a significant increase of 9.16% compared to the previous year. However, in the last quarter, total revenue was reported at $1.53 billion, holding flat compared to the previous quarter. Net income for CHD was reported at $755.60 million over the past year, showing a substantial increase of 82.56% compared to the previous year. Similar to total revenue, net income held flat in the last quarter at $153.70 million. Earnings per share (EPS) for CHD were reported at $3.05 over the past year, marking an increase of 81.59% compared to the previous year. However, in the last quarter, EPS decreased by 12.81% to $0.62. Overall, CHD stock performance on February 23, 2024, showed mixed results. Investors may want to closely monitor CHD’s financial performance in the coming quarters to see if the company is able to sustain its growth trajectory.

Tags: CHD
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Electric Utilities Stock Exchange

Franklin Electric Receives Upgrade to Buy Rating from Northcoast Research Analyst

Consumer Goods Stock Market Today

Analyst Sentiments and Price Targets for Church Dwight Co NYSECHD

MO stock news

Analyst Ratings and Target Prices for Lantheus Holdings Insights and Trends

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com